---
title: "CHAIN BRIDGE I | 10-Q: FY2025 Q3 Revenue: USD 0"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/265991518.md"
datetime: "2025-11-14T22:16:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265991518.md)
  - [en](https://longbridge.com/en/news/265991518.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265991518.md)
generator: "portal-rs"
---

# CHAIN BRIDGE I | 10-Q: FY2025 Q3 Revenue: USD 0

Revenue: As of FY2025 Q3, the actual value is USD 0.

EPS: As of FY2025 Q3, the actual value is USD -0.21.

EBIT: As of FY2025 Q3, the actual value is USD -292.67 K.

### General and Administrative Expenses

-   For the three months ended September 30, 2025, expenses were $235,955, compared to $749,158 for the same period in 2024. For the nine months ended September 30, 2025, expenses were $763,088, compared to $1,882,579 in 2024.

### Net Loss

-   For the three months ended September 30, 2025, the net loss was approximately $1,300,000, compared to a net income of $326,000 for the same period in 2024. For the nine months ended September 30, 2025, the net loss was approximately $1,700,000, compared to a net loss of $1.4 million in 2024.

### Net Cash Used in Operating Activities

-   For the nine months ended September 30, 2025, net cash used in operating activities was - $410,927, compared to - $626,508 for the same period in 2024.

### Income from Investments Held in Trust Account

-   For the three months ended September 30, 2025, income was $56,719, compared to $147,634 for the same period in 2024. For the nine months ended September 30, 2025, income was $168,010, compared to $636,883 in 2024.

### Future Outlook and Strategy

-   **Core Business Focus**: The company has until November 15, 2026, to consummate an initial Business Combination. If not completed by this date, the company must cease operations, redeem public shares, and liquidate.
-   **Non-Core Business**: The company is exploring a Business Combination with Phytanix Bio, which involves merging with CB Merger Sub and Phytanix Merger Sub, with the company and Phytanix becoming wholly owned subsidiaries of HoldCo.

### Related Stocks

- [CBRGF.US](https://longbridge.com/en/quote/CBRGF.US.md)

## Related News & Research

- [Why is your gold waiting on a speech?](https://longbridge.com/en/news/296733808.md)
- [North Sea Crude-WTI weakens on lower offer](https://longbridge.com/en/news/296813963.md)
- [Nvidia Earnings: Wall Street Expects Growth to Slow in Q2 — Dan Niles Says Hyperscalers Are Spending Like Never Before](https://longbridge.com/en/news/296822352.md)
- [There’s More to Consider, Says Investor About Sandisk Stock](https://longbridge.com/en/news/296795615.md)
- [AMD or Nvidia: Load Up on One AI Chip Stock, but Avoid the Other, Says Investor](https://longbridge.com/en/news/296792383.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**